title: Immunohistochemical expression of vimentin and secretory component antigens in endometrial hyperplasia and neoplasia.
abstract: Vimentin is an intermediate filament protein normally expressed in mesenchymal cells, but evidence is accumulating in the literature which suggests that the aberrant expression of vimentin in epithelial cancer cells might be related to local invasiveness and metastatic potential. Previous studies strongly support the implication of vimentin in the metastatic progression of breast and cervical lesions. The secretory component is isolated from human colostrum and is of help in more precise grading of endometrial carcinoma. In this study we examined vimentin and secretory component (SC) expression in adenomatous hyperplasia, atypical adenomatous hyperplasia and well-differentiated adenocarcinoma (cribriform pattern). The results showed decreased expression of vimentin and increased expression of the secretory component as the lesion progressed to malignancy.
authors.affiliation: Department of Histology-Embryology, Democritus University of Thrace, Alexandroupolis, Greece.
authors.forename: N
authors.initials: N
authors.lastname: Papadopoulos
authors.forename: A
authors.initials: A
authors.lastname: Kotini
authors.forename: A
authors.initials: A
authors.lastname: Cheva
authors.forename: T
authors.initials: T
authors.lastname: Jivannakis
authors.forename: M
authors.initials: M
authors.lastname: Lambropoulou
authors.forename: M
authors.initials: M
authors.lastname: Bobos
authors.forename: S
authors.initials: S
authors.lastname: Vavetsis
authors.forename: D
authors.initials: D
authors.lastname: Tamiolakis
mesh_terms: D000230:Adenocarcinoma / Q000276:immunology / Q000473:pathology*; D001324:Autoantigens / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D001707:Biopsy, Needle; D015331:Cohort Studies; D003937:Diagnosis, Differential; D004714:Endometrial Hyperplasia / Q000276:immunology / Q000473:pathology*; D016889:Endometrial Neoplasms / Q000276:immunology / Q000473:pathology*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D011379:Prognosis; D012635:Secretory Component / Q000032:analysis* / Q000276:immunology; D012680:Sensitivity and Specificity; D014746:Vimentin / Q000032:analysis*
chemical_list: D001324:Autoantigens; D014408:Biomarkers, Tumor; D012635:Secretory Component; D014746:Vimentin